your opinion was the UK trial is "fluff", and a pivot from the US to UK.
My opinion is that the trial is valuable and the US remains the focus.
I stand by my comments. HC is not the place to validate your investment. Go and speak with medical/clinical experts and ask what they think about the UK trial process, and US commercialisation strategy.
Discussion has been had. Happy to move on as you suggest. All the best.
- Forums
- ASX - By Stock
- RSH
- Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial
Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial, page-38
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RSH (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $72.29M |
Open | High | Low | Value | Volume |
5.6¢ | 5.8¢ | 5.4¢ | $68.00K | 1.217M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 219787 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 73162 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 219787 | 0.053 |
2 | 112000 | 0.047 |
1 | 311458 | 0.046 |
4 | 1172112 | 0.045 |
2 | 235399 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 73162 | 2 |
0.056 | 232536 | 2 |
0.057 | 200000 | 1 |
0.058 | 35000 | 1 |
0.060 | 100000 | 1 |
Last trade - 10.13am 15/10/2024 (20 minute delay) ? |
Featured News
RSH (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online